サクサク読めて、アプリ限定の機能も多数！
タグをすべて表示
ランキング
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
IVERIC bio’s Zimura®, a Novel Complement C5 Inhibitor, Met its Primary Endpoint and Reached Statistical Significance in a Phase 2b Randomized, Controlled Clinical Trial in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Cortexyme Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2019
Minerva Biotechnologies Announces FDA Acceptance of IND Application for huMNC2-CAR44 T cells to Treat Metastatic Breast Cancer
Oligomerix, Inc Receives Ongoing Support for Tau Oligomer Inhibitor Program from National Institutes of Health
Epizyme Submits New Drug Application to the U.S. FDA for Tazemetostat for the Treatment of Patients with Epithelioid Sarcoma
Merck’s BELSOMRA® (suvorexant) C-IV Meets Primary Efficacy Endpoint in Phase 3 Trial for the Treatment of Insomnia in People with Mild-to-Moderate Alzheimer’s Disease Dementia
Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus
Maxinovel‘s Orally Active PD-L1 Inhibitor Demonstrating Similar Efficacy to PD-L1 Antibody Durvalumab
GenAhead Bio：ERS GenomicsとCRISPR / Cas9技術基本特許における非独占的ライセンス契約を締結 | Business Wire
CSPC Pharmaceutical Group Limited and Verastem Oncology Sign Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China
SanBio: Joint Research Agreement for SB623 Targeting Dementia
Cullgen Announces Expanded Scientific Advisory Board
MiNA Therapeutics to Present Initial Results from First-in-Human MTL-CEBPA Study at the 2018 ASCO Annual Meeting
Evotec and Carna Biosciences Collaborate on Indigo Platform
vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in People with Mild Alzheimer’s Disease
Cullgen Announces ALK PROTACs Publication by Its Co-founders in the European Journal of Medicinal Chemistry
ArQule to Present Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
Sosei Regains Worldwide Rights from Teva to Develop and Commercialize Novel Small Molecule CGRP Antagonists for Migraine and Other Severe Headaches
MiNA Therapeutics Announces Publication of Pre-Clinical Data Supporting Therapeutic Potential of Clinical Candidate MTL-CEBPA in Liver Cancer and Liver Disease
Changes in Executive Management at Sosei